(Q37803301)

23 August 2017

title

Spironolactone management of resistant hypertension (English)

1 reference

23 August 2017

Spironolactone Management of Resistant Hypertension (English)

1 reference

10 August 2024

main subject

arterial hypertension

0 references

Joel C. Marrs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20978214

10 August 2024

language of work or name

English

0 references

publication date

26 October 2010

1 reference

full work available at URL

23 August 2017

http://www.theannals.com/cgi/content/abstract/44/11/1762

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20978214

http://journals.sagepub.com/doi/pdf/10.1345/aph.1P338

10 August 2024

1 reference

Annals of Pharmacotherapy

10 August 2024

published in

1 reference

23 August 2017

volume

44

1 reference

23 August 2017

issue

11

1 reference

23 August 2017

page(s)

1762-1769

1 reference

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

23 August 2017

cites work

1 reference

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research

21 January 2018

1 reference

Aldosterone-receptor antagonism in hypertension

21 January 2018

1 reference

Aldosterone escape during ACE inhibitor therapy in chronic heart failure

21 January 2018

1 reference

Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

21 January 2018

1 reference

Aldosterone receptor antagonists: effective but often forgotten

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis

21 January 2018

1 reference

Prolonged alteration of renin responsiveness after spironolactone therapy. A cause of false-negative testing for low-renin hypertension.

21 January 2018

1 reference

The role of spironolactone in the treatment of patients with refractory hypertension

21 January 2018

1 reference

Efficacy of low-dose spironolactone in subjects with resistant hypertension

21 January 2018

1 reference

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

Low-dose spironolactone in the management of resistant hypertension: a surveillance study

21 January 2018

1 reference

Efficacy of spironolactone therapy in patients with true resistant hypertension.

21 January 2018

1 reference

Predictors of hyperkalemia risk following hypertension control with aldosterone blockade

21 January 2018

1 reference

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

21 January 2018

1 reference

Clinical relevance of drug interactions with lithium

21 January 2018

1 reference

Renal complications of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

Differential Control of Systolic and Diastolic Blood Pressure

21 January 2018

1 reference

Treatment and Control of Hypertension in the Community

21 January 2018

1 reference

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled

21 January 2018

1 reference

Efficacy of Add-On Aldosterone Receptor Blocker in Uncontrolled Hypertension

21 January 2018

1 reference

Aldosterone antagonist therapy in resistant hypertension

21 January 2018

7

1 reference

Use of aldosterone antagonists in resistant hypertension

10 August 2024

8

1 reference

Experience with the Use of an Aldosterone Antagonist in Selected Hypertensive Patients

10 August 2024

16

1 reference

Integrating traditional and emerging treatment options in heart failure.

10 August 2024

18

1 reference

Drug Metabolism and Disposition

10 August 2024

19

22

903

Los LE

1994

1 reference

Effect of spironolactone on blood pressure in subjects with resistant hypertension

10 August 2024

24

1 reference

Interaction of Diuretics and Non-Steroidal Anti-Inflammatory Drugs in Man

10 August 2024

30

1 reference

Interactions between digoxin and potassium-sparing diuretics

10 August 2024

32

1 reference

The interaction of spironolactone and digoxin: a review and evaluation.

10 August 2024

33

1 reference

10 August 2024

Identifiers

DOI

10.1345/APH.1P338

1 reference

23 August 2017

1 reference